Verition Fund Management
GILD icon

Verition Fund Management’s Gilead Sciences GILD Stock Holding History

Verition Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Buy
10,400
+1,000
+11% +$140K 0.01% 1169
2025
Q4 		$1.15M Sell
9,400
-32,800
-78% -$3.99M ﹤0.01% 2049
2025
Q3 		$4.68M Buy
42,200
+2,900
+7% +$330K 0.02% 1222
2025
Q2 		$4.36M Buy
39,300
+17,400
+79% +$1.85M 0.02% 1274
2025
Q1 		$2.45M Buy
21,900
+6,300
+40% +$650K 0.01% 1431
2024
Q4 		$1.44M Sell
15,600
-38,200
-71% -$3.44M 0.01% 1786
2024
Q3 		$4.51M Buy
53,800
+8,400
+19% +$641K 0.02% 916
2024
Q2 		$3.11M Buy
45,400
+30,000
+195% +$2M 0.02% 1019
2024
Q1 		$1.13M Buy
+15,400
New +$1.18M 0.01% 1545
2022
Q4 		– Sell
-10,500
Closed -$648K – 2367
2022
Q3 		$648K Buy
+10,500
New +$662K 0.01% 1706
2022
Q2 		– Sell
-50,300
Closed -$2.99M – 2611
2022
Q1 		$2.99M Buy
50,300
+30,400
+153% +$1.94M 0.04% 684
2021
Q4 		$1.45M Buy
+19,900
New +$1.37M 0.01% 1075
2020
Q2 		– Sell
-80,000
Closed -$5.98M – 1095
2020
Q1 		$5.98M Buy
+80,000
New +$5.53M 0.24% 78

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Verition Fund Management's GILD Position: Q1 2026 in Review

Verition Fund Management reduced its Gilead Sciences (GILD) stake by 90% in Q1 2026, selling an estimated $8.61M and leaving 6,709 shares worth $935K. The position accounts for 0.01% of the portfolio, ranked #1334.

Verition Fund Management first reported a position in GILD in Q3 2013 and has held it in 38 quarters since. The position peaked at $33.2M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Verition Fund Management held 6,709 shares of Gilead Sciences worth $935K as of Q1 2026.
  • Verition Fund Management sold 61,468 Gilead Sciences shares in Q1 2026, an estimated $8.61M.
  • Gilead Sciences made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1334 holding.
  • Verition Fund Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 38 quarters since.
  • Verition Fund Management's Gilead Sciences position peaked at $33.2M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.